Teva Pharmaceutical Industries Lt.../ US8816242098 /
| 08/11/2024 22:10:00 | Chg. -0.39 | Volume | Bid11:08:39 | Ask11:08:39 | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 17.11USD | -2.23% | 6.23 mill. Turnover: 93.81 mill. |
17.46Bid Size: 3,200 | 17.50Ask Size: 200 | -USD | - | - |
Assets
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 6,436 | 6,296 | 5,982 | 5,739 | 5,750 | ||||||
| Intangible Assets | 11,232 | 8,923 | 7,466 | 6,270 | 5,387 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | - | 37,635 | 35,093 | 31,955 | 30,994 | ||||||
| Inventories | 4,422 | 4,403 | 3,818 | 3,833 | 4,021 | ||||||
| Accounts Receivable | 5,676 | 4,581 | 4,529 | 3,696 | 3,408 | ||||||
| Cash and Cash Equivalents | 1,975 | 2,177 | 2,165 | 2,801 | 3,226 | ||||||
| Current Assets | 13,464 | 13,005 | 12,573 | 12,051 | 12,485 | ||||||
| Total Assets | 57,470 | 50,640 | 47,666 | 44,006 | 43,479 | ||||||
Liabilities
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 1,718 | 1,756 | 1,686 | 1,887 | 2,602 | ||||||
| Long-term debt | - | 22,731 | 21,617 | 19,103 | 18,161 | ||||||
| Liabilities to Banks | 2,345 | 3,188 | 1,426 | - | - | ||||||
| Provisions | 1,096 | 964 | 784 | - | - | ||||||
| Liabilities | 42,407 | 39,579 | 36,422 | 35,315 | 35,353 | ||||||
| Share Capital | 56 | 57 | 57 | 57 | 57 | ||||||
| Total Equity | 13,972 | 11,061 | 11,244 | 8,691 | 8,126 | ||||||
| Minority Interests | 1,091 | 1,035 | 966 | 794 | 620 | ||||||
| Total liabilities equity | 57,470 | 50,640 | 47,666 | 44,006 | 43,479 | ||||||
Income Statement
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 16,887 | 16,659 | 15,878 | 14,925 | 15,846 | ||||||
| Depreciation (total) | - | 1,557 | 1,330 | 1,308 | 1,153 | ||||||
| Operating Result | -443 | -3,572 | 1,716 | -2,099 | 433 | ||||||
| Interest Income | -822 | 834 | 1,058 | 966 | 1,057 | ||||||
| Income Before Taxes | -1,265 | -4,406 | 658 | -3,065 | -624 | ||||||
| Income Taxes | -278 | -168 | 211 | -638 | -7 | ||||||
| Minority Interests Profit | 1 | -109 | 39 | -53 | -56 | ||||||
| Net Income | -999 | -3,990 | 417 | -2,353 | -559 | ||||||
Per Share
Cash Flow
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 748 | 1,216 | 798 | 1,590 | 1,368 | ||||||
| Cash Flow from Investing Activities | 1,355 | 863 | 1,523 | 656 | 968 | ||||||
| Cash Flow from Financing | -1,926 | -1,885 | -2,172 | -1,487 | -1,913 | ||||||
| Decrease / Increase in Cash | 193 | 202 | 21 | 636 | 393 | ||||||
| Employees | 40,039 | 40,216 | 37,537 | - | - | ||||||
